Table 2.

Treatment-induced changes in circulating Flt3L levels and correlations with cytotoxic effects – Oslo study

Measure of cytotoxicity	Post NACT			Post CRT
	N	r	P	N	r	P
Haemoglobin	56	–0.38	<0.01	49	0.02	0.87
Thrombocytes	56	–0.07	0.62	49	–0.34	0.02
Neutrophils	56	–0.36	0.01	49	–0.19	0.19
Lymphocytes	54	0.27	0.05	47	0.11	0.46
Monocytes	53	0.07	0.60	40	0.47	0.01
Tumour ΔVa	49	–0.32	0.03	43	0.07	0.67

CRT chemoradiotherapy, Flt3L fms-like tyrosine kinase 3 ligand, NACT neoadjuvant chemotherapy

^aΔV denotes ∆V_NACT post NACT and ∆V_CRT post CRT